Area of research
Hematology · Speech and Hearing
Research interest
Research focused on Rheumatology and Macrophage activation syndrome, with related work in Arthritis, Rheumatism, Single-nucleotide polymorphism. Notable publications include '2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of...', 'Classification criteria for autoinflammatory recurrent fevers', and 'Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients'.
Classification criteria for autoinflammatory recurrent fevers
Consensus-based recommendations for the management of juvenile localised scleroderma
Treating juvenile idiopathic arthritis to target: recommendations of an international task force
Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind
<i>IL1RN</i> Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin‐1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis
Blau Syndrome–Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Development of the autoinflammatory disease damage index (ADDI)
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Recommendations for the management of autoinflammatory diseases
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial
<i>HLA-DRB1*11</i>and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes
A preliminary disease severity score for juvenile systemic sclerosis